{"AllianceGenome": "11853", "HGNC": "11853", "MIM": "191155", "_id": "4071", "_version": 1, "accession": {"genomic": ["AC073522.19", "AC108751.10", "CH471052.2", "CP068275.2", "NC_000003.12", "NC_060927.1"], "protein": ["AAA36158.1", "AAH08442.1", "AAH10166.1", "AAH34145.1", "CAG33234.1", "EAW78874.1", "EAW78875.1", "EAW78876.1", "NP_001397766.1", "NP_055035.1", "P30408.1", "WBY73523.1", "XP_016861874.1", "XP_054202489.1"], "rna": ["AK093829.1", "AK130073.1", "AK130271.1", "AL832780.1", "BC008442.1", "BC010166.2", "BC034145.1", "BG142206.1", "BI494959.1", "CR456953.1", "M90657.1", "NM_001410837.1", "NM_014220.3", "OP680446.1", "X75684.1", "XM_017006385.3", "XM_054346514.1"], "translation": [{"protein": "XP_016861874.1", "rna": "XM_017006385.3"}, {"protein": "AAH08442.1", "rna": "BC008442.1"}, {"protein": "XP_054202489.1", "rna": "XM_054346514.1"}, {"protein": "NP_055035.1", "rna": "NM_014220.3"}, {"protein": "AAH10166.1", "rna": "BC010166.2"}, {"protein": "NP_001397766.1", "rna": "NM_001410837.1"}, {"protein": "AAH34145.1", "rna": "BC034145.1"}, {"protein": "WBY73523.1", "rna": "OP680446.1"}, {"protein": "AAA36158.1", "rna": "M90657.1"}, {"protein": "CAG33234.1", "rna": "CR456953.1"}]}, "alias": ["H-L6", "L6", "M3S1", "TAAL6"], "ensembl": {"gene": "ENSG00000169908", "protein": ["ENSP00000304277", "ENSP00000417084", "ENSP00000418025", "ENSP00000419426"], "transcript": ["ENST00000305366", "ENST00000472441", "ENST00000493298", "ENST00000493348"], "translation": [{"protein": "ENSP00000304277", "rna": "ENST00000305366"}, {"protein": "ENSP00000417084", "rna": "ENST00000472441"}, {"protein": "ENSP00000419426", "rna": "ENST00000493348"}, {"protein": "ENSP00000418025", "rna": "ENST00000493298"}], "type_of_gene": "protein_coding"}, "entrezgene": "4071", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.48286851, "exp_mis": 65.8067268, "exp_syn": 31.5854053, "lof_z": 1.12035815889068, "mis_z": -0.795488178146095, "mu_lof": 6.52007953748e-07, "mu_mis": 5.62313048952e-06, "mu_syn": 2.60277020619e-06, "n_lof": 6.0, "n_mis": 79.0, "n_syn": 35.0, "p_li": 0.000859110031523055, "p_null": 0.209239055238172, "p_rec": 0.789901834730305, "syn_z": -0.376655904625637}, "bp": 609, "cds_end": 149095334, "cds_start": 149087652, "n_exons": 5, "nonpsych": {"exp_lof": 8.4797331, "exp_mis": 59.4582617, "exp_syn": 28.4846616, "lof_z": 1.17356405539095, "mis_z": -0.951200305508304, "mu_lof": 6.52007953748e-07, "mu_mis": 5.62313048952e-06, "mu_syn": 2.60277020619e-06, "n_lof": 5.0, "n_mis": 74.0, "n_syn": 31.0, "p_li": 0.00366390161396324, "p_null": 0.173557389666066, "p_rec": 0.822778708719971, "syn_z": -0.296725376676236}, "nontcga": {"exp_lof": 8.71418219, "exp_mis": 60.5321357, "exp_syn": 29.04851678, "lof_z": 1.24116971949747, "mis_z": -0.798378531208136, "mu_lof": 6.52007953748e-07, "mu_mis": 5.62313048952e-06, "mu_syn": 2.60277020619e-06, "n_lof": 5.0, "n_mis": 73.0, "n_syn": 33.0, "p_li": 0.00375017550473656, "p_null": 0.14796982614345, "p_rec": 0.848279998351813, "syn_z": -0.46421599171049}, "transcript": "ENST00000305366.3"}, "exons": [{"cdsend": 149377547, "cdsstart": 149369865, "chr": "3", "position": [[149369021, 149369880], [149371686, 149371867], [149375442, 149375588], [149375679, 149375769], [149377370, 149377649]], "strand": -1, "transcript": "NM_014220", "txend": 149377649, "txstart": 149369021}], "exons_hg19": [{"cdsend": 149095334, "cdsstart": 149087652, "chr": "3", "position": [[149086808, 149087667], [149089473, 149089654], [149093229, 149093375], [149093466, 149093556], [149095157, 149095436]], "strand": -1, "transcript": "NM_014220", "txend": 149095436, "txstart": 149086808}], "generif": [{"pubmed": 12855661, "text": "TAL6 may play a role in cancer invasion and metastasis"}, {"pubmed": 18270265, "text": "These data suggest that L6-Ag influences cell motility via TERM by regulating the surface presentation and endocytosis of some of their components."}, {"pubmed": 19401544, "text": "The gene ratio test with the TM4SF1 gene for survival of patients with malignant pleural mesothelioma has robust predictive value."}, {"pubmed": 20486778, "text": "TM4SF1 can serve as a surface protein marker which singly identifies MSCs from diverse cell sources, in particular, fibroblast-rich connective tissues"}, {"pubmed": 21569526, "text": "We provide evidence that ARHGDIA, COBLL1, and TM4SF1 are negative regulators of apoptosis in cultured tumor cells."}, {"pubmed": 21626280, "text": "TM4SF1, like genuine tetraspanins, serves as a molecular organizer that interacts with membrane and cytoskeleton-associated proteins and uniquely initiates the formation of nanopodia and facilitates cell polarization and migration."}, {"pubmed": 21656834, "text": "Inhibition of cell migration after targeted knockdown of TM4SF1 protein expression suggests its contribution to prostate cancer cell metastasis."}, {"pubmed": 24285464, "text": "High TM4SF1 expression is associated with pancreatic cancer."}, {"pubmed": 24986520, "text": "TM4SF1 is a small plasma membrane glycoprotein that regulates cell motility and proliferation, and possibly a new vascular therapeutic target in cancer"}, {"pubmed": 25855954, "text": "Transmembrane-4-L-six-family-1 is overexpressed in human gliomas in general and the precise level of expression might predict outcome and could be of clinical value."}, {"pubmed": 25872484, "text": "We found that miR-203 was significantly downregulated in OSF tissues compared to that in normal buccal mucosa tissues, and that miR-203 negatively regulated secreted SFRP4 and positively regulated TM4SF1"}, {"pubmed": 26035794, "text": "Study shows that TM4SF1 expression is associated with better prognosis in pancreatic cancer. Its loss contributes to the invasion and migration of pancreatic cancer cells."}, {"pubmed": 26241677, "text": "These findings validate TM4SF1 as an attractive candidate for cancer therapy with antibody-bound toxins that have the capacity to react with either cytoplasmic or nuclear targets in tumor cells or tumor-associated vascular endothelium."}, {"pubmed": 26464650, "text": "TM4SF1 overexpression significantly contributed MDA-MB-231 cell migration but decreased apoptotic cells"}, {"pubmed": 26709920, "text": "The findings suggest that TM4SF1 is a surface membrane antigen that is highly expressed in pancreatic cancer cells and increases the chemoresistance to gemcitabine. TM4SF1 may be a promising target to overcome the chemoresistance of pancreatic cancer."}, {"pubmed": 26983891, "text": "Results show that TM4SF1 expression is elevated in colorectal cancer (CRC), and associated with tumor stage and lymph node metastasis. Also, miR-9 directly targeted its binding site in the TM4SF1 3'-UTR, which has a critical role in regulating CRC cell migration. and invasion. Furthermore, miR-9 regulated cell motility via suppressing"}, {"pubmed": 27459514, "text": "Results indicate that the expression of transmembrane 4 L6 family member 1 (TM4SF1) is higher in pancreatic cancer tissues and pancreatic cancer cell lines than controls."}, {"pubmed": 27974706, "text": "High TM4SF1 expression is associated with esophageal cancer."}, {"pubmed": 28129652, "text": "Replacement of the transmembrane 4 L six family protein TM4SF1 or TM4SF4 C-terminus with that of TM4SF5 increased spheroids growth, transwell migration, and invasive dissemination from spheroids in 3D collagen gels."}, {"pubmed": 28368050, "text": "our study provides a novel regulatory pathway involving TM4SF1, DDR1, MMP2 and MMP9, which promotes the formation and function of invadopodia to support cell migration and invasion in pancreatic cancer."}, {"pubmed": 28528497, "text": "Results suggest that miR-30a is an important regulator of TM4SF1, VEGF, and E-cadherin for CRC lymph node metastasis, a potential new therapeutic target in CRC."}, {"pubmed": 29175458, "text": "Regulation of transmembrane-4-L-six-family-1 (TM4SF1) on bladder cancer cell could be induced by peroxisome proliferator-activated receptor gamma (PPARgamma)-sirtuin 1 (SIRT1) feedback loop."}, {"pubmed": 29505836, "text": "TM4SF1 was recognized as a direct target for miR-520f in hepatocellular carcinoma (HCC) cells where its expression was found up-regulated and inversely correlated with that of mir-520f."}, {"pubmed": 29665316, "text": "These data suggested that low expression of TM4SF1 is associated with carcinogenesis and development, tumor progression and invasion of gastric cancer, and poor overall survival of patients with GC. TM4SF1 is a tumor suppressor for GC and a novel prognostic marker for patients with GC."}, {"pubmed": 30135139, "text": "These results could be reversed by the overexpression of TM4SF1. At last, up-regulation of miR-206 suppressed expression of p-AKT and p-ERK by targetting TM4SF1 in PGE2-induced cells.Our results provide further evidence that miR-206 has a protective effect on PGE2-induced colon carcinogenesis."}, {"pubmed": 30301667, "text": "our data provide the first evidence that TM4SF1 is a direct target of miR-30a/c and miR-30a/c inhibits the stemness and proliferation of NSCLC cells by targeting TM4SF1, suggesting that miR-30a/c and TM4SF1 may be useful as tumor biomarkers for the diagnosis and treatment of NSCLC patients."}, {"pubmed": 30876464, "text": "Results find that TM4SF1 has selective expression features in epithelial ovarian tumors, can mediate tumor cell growth and invasion, as well as metastasis, and is closely associated with anti-tumor immune responses."}, {"pubmed": 31876386, "text": "TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling."}, {"pubmed": 31983129, "text": "High TM4SF1 expression is associated with metastasis in prostate cancer."}, {"pubmed": 32141552, "text": "TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway."}, {"pubmed": 32376266, "text": "found miR-1-3p and miR-214-5p targeted TM4SF1, inhibited TM4SF1 expression, cell proliferation, migration, and induced apoptosis in human keloid fibroblasts"}, {"pubmed": 33153498, "text": "TM4SF1 promotes EMT and cancer stemness via the Wnt/beta-catenin/SOX2 pathway in colorectal cancer."}, {"pubmed": 34118595, "text": "HIF-1alpha-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression."}, {"pubmed": 35081723, "text": "Hyper-expression and hypomethylation of TM4SF1 are associated with lymph node metastases in papillary thyroid carcinoma patients."}, {"pubmed": 35532297, "text": "TM4SF1 promotes glioma malignancy through multiple mechanisms."}, {"pubmed": 35730016, "text": "Long Noncoding RNA BCYRN1 Recruits BATF to Promote TM4SF1 Upregulation and Enhance HCC Cell Proliferation and Invasion."}, {"pubmed": 35835740, "text": "TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin alpha6."}, {"pubmed": 36252184, "text": "Tm4sf1-marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension."}, {"pubmed": 36274500, "text": "MicroRNA-501-3p targeting TM4SF1 facilitates tumor-related behaviors of gastric cancer cells via EMT signaling pathway."}, {"pubmed": 37069693, "text": "TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC."}, {"pubmed": 38251858, "text": "Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF-kappaB pathway, and elevated MMP13 expression."}], "genomic_pos": {"chr": "3", "end": 149377692, "ensemblgene": "ENSG00000169908", "start": 149369022, "strand": -1}, "genomic_pos_hg19": {"chr": "3", "end": 149095652, "start": 149086809, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001825", "qualifier": "involved_in", "term": "blastocyst formation"}, {"evidence": "ND", "gocategory": "BP", "id": "GO:0008150", "qualifier": "involved_in", "term": "biological_process"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 7510285, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0016020", "qualifier": "is_active_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "ND", "id": "GO:0003674", "qualifier": "enables", "term": "molecular_function"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 11102519, "qualifier": "enables", "term": "protein binding"}]}, "homologene": {"genes": [[8364, 100151707], [9031, 425046], [9544, 711908], [9598, 460770], [9606, 4071], [9913, 533038], [10090, 17112], [10116, 295061]], "id": 7409}, "interpro": {"desc": "L6 membrane", "id": "IPR008661", "short_desc": "L6_membrane"}, "ipi": ["IPI00744287", "IPI00796433", "IPI00797540", "IPI00798263"], "map_location": "3q25.1", "name": "transmembrane 4 L six family member 1", "other_names": ["membrane component, chromosome 3, surface marker 1", "transmembrane 4 L6 family member 1", "transmembrane 4 superfamily member 1", "tumor-associated antigen L6"], "pantherdb": {"HGNC": "11853", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "104678", "ortholog_type": "LDO", "panther_family": "PTHR14198", "taxid": 10090, "uniprot_kb": "Q64302"}, {"RGD": "1309652", "ortholog_type": "LDO", "panther_family": "PTHR14198", "taxid": 10116, "uniprot_kb": "D4ACP4"}, {"Ensembl": "ENSGALG00000054252", "ortholog_type": "LDO", "panther_family": "PTHR14198", "taxid": 9031, "uniprot_kb": "A0A1D5NY90"}, {"ZFIN": "ZDB-GENE-050208-690", "ortholog_type": "LDO", "panther_family": "PTHR14198", "taxid": 7955, "uniprot_kb": "E7FBS4"}], "uniprot_kb": "P30408"}, "pfam": "PF05805", "pharmgkb": "PA36554", "pharos": {"target_id": 17031, "tdl": "Tbio"}, "pir": "A42926", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167984", "relationship": "is"}, {"id": "GNF178890", "relationship": "is"}, {"id": "GNF189796", "relationship": "is"}, {"id": "GNF200702", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF160884", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF046055", "relationship": "is"}, {"id": "GNF046708", "relationship": "is"}, {"id": "GNF047486", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF014636", "relationship": "is"}, {"id": "GNF014637", "relationship": "is"}, {"id": "GNF014638", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF113659", "relationship": "is"}, {"id": "GNF153300", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1"], "protein": ["NP_001397766.1", "NP_055035.1", "XP_016861874.1", "XP_054202489.1"], "rna": ["NM_001410837.1", "NM_014220.3", "XM_017006385.3", "XM_054346514.1"], "translation": [{"protein": "XP_016861874.1", "rna": "XM_017006385.3"}, {"protein": "XP_054202489.1", "rna": "XM_054346514.1"}, {"protein": "NP_001397766.1", "rna": "NM_001410837.1"}, {"protein": "NP_055035.1", "rna": "NM_014220.3"}]}, "reporter": {"HG-U133_Plus_2": ["209386_at", "209387_s_at", "215033_at", "215034_s_at", "238168_at"], "HG-U95Av2": ["41531_at", "892_at"], "HTA-2_0": "TC03001888.hg.1", "HuEx-1_0": "2700365", "HuGene-1_1": "8091411", "HuGene-2_1": "16960355"}, "retired": 9004, "summary": "The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface antigen and is highly expressed in different carcinomas. [provided by RefSeq, Jul 2008].", "symbol": "TM4SF1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C0920268"}, "unigene": "Hs.351316", "uniprot": {"Swiss-Prot": "P30408", "TrEMBL": ["F8WBG6", "F8WF27", "C9J611"]}, "wikipedia": {"url_stub": "TM4SF1"}}